These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8767066)

  • 21. [Comparison of angiotensin receptor antagonists and angiotensin converting enzyme inhibitors in arterial hypertension].
    Krezsinski JM; Sternon J
    Rev Med Brux; 2000 Jun; 21(3):170-7. PubMed ID: 10925600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antihypertensive therapy using a combination of angiotensin-1 receptor inhibitors and angiotensin-converting enzyme inhibitors].
    Schute L
    Dtsch Med Wochenschr; 1998 Oct; 123(43):1295. PubMed ID: 9818002
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of angiotensin converting enzyme inhibitors in nephrology].
    Stefanović V; Ivić M; Bogićević M
    Srp Arh Celok Lek; 1994; 122(7-8):228-30. PubMed ID: 17974394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are elderly people with the HOPE criteria prescribed angiotensin-converting enzyme inhibitors?
    Sumukadas D; Witham MD; Struthers AD; McMurdo ME
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):26. PubMed ID: 15136970
    [No Abstract]   [Full Text] [Related]  

  • 26. Current focus on cardiovascular function with angiotensin converting enzyme inhibitors in hypertension.
    J Hypertens Suppl; 1992 Jul; 10(5):S1-101. PubMed ID: 1403228
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The current status and outlook of the treatment of arterial hypertension with converting enzyme inhibitors].
    Gherasim L; Dorobanţu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(6):491-508. PubMed ID: 2908153
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypertension and progression of renal disease.
    Maschio G; Oldrizzi L; Marcantoni C; Rugiu C
    J Nephrol; 2000; 13(3):225-7. PubMed ID: 10928300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension].
    Horký K
    Vnitr Lek; 1996 Feb; 42(2):110-3. PubMed ID: 8686183
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rationale for the use of renin-angiotensin inhibitors in the treatment of arterial hypertension and correlated organ damage].
    Mammarella A; Paoletti V; De Matteis A; Di Franco M; Cavina G; Paradiso M
    Clin Ter; 2002; 153(1):45-9. PubMed ID: 11963634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

  • 33. ACE inhibitors and the kidney. Proceedings of a satellite symposium held in conjunction with the International Society of Hypertension. Kyoto, Japan, May 21, 1988.
    Nephron; 1990; 55 Suppl 1():1-98. PubMed ID: 2345588
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced atrial fibrillation incidence by angiotensin-converting enzyme inhibitors: a possible contributing mechanism.
    El Muayed M
    J Am Coll Cardiol; 2005 Apr; 45(7):1144; author reply 1144. PubMed ID: 15808777
    [No Abstract]   [Full Text] [Related]  

  • 35. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
    Griffin KA; Bidani AK
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ACE-inhibitors indicated even in non-diabetic nephropathy].
    Internist (Berl); 1996 Oct; 37(10 Suppl Ace-hemmer):1-8. PubMed ID: 9402421
    [No Abstract]   [Full Text] [Related]  

  • 38. [Angiotensin converting enzyme inhibitors in arterial hypertension].
    Ramón González-Juanatey J
    Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Scleroderma renal crisis (SRC): hypertensive, normotensive].
    Endo H
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):656-60. PubMed ID: 11210764
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current features of antihypertensive drug treatment].
    Luño J; García de Vinuesa S
    Rev Clin Esp; 1999 Dec; 199(12):834-9. PubMed ID: 10687418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.